Mylan Ends Calif. Drug Price Inflation Claims For $57M
Mylan Inc. will pay $57 million to resolve all claims by the state of California and a relator in multidistrict litigation accusing the drugmaker of reporting inflated average wholesale prices of...To view the full article, register now.
Already a subscriber? Click here to view full article